Find the next disease your drug can treat.
Akkad Labs writes evidence reviews for small neuroscience biotechs. Each one ranks the diseases your compound has the strongest case for, with every claim linked to its source.
Ask about a reviewWhat a review covers
Ranked candidate diseases
A shortlist of indications, ordered by strength of evidence and fit for a company your size.
The biology behind each one
Why the target matters in that disease, from cell studies through any human trials.
Competing and failed programs
Who else is working on the target, what they tried, and what happened.
Risks and a first experiment
The weak points in the case, and the cheapest test that would confirm or kill it.
How it works
Send the compound
Tell me the drug and the diseases you already plan to pursue.
Get the review
A short, fully sourced report on where else it could work.
Talk it through
A call to go over the findings and what to do next.
About
Akkad Labs is run by Gabriel Amsih, a student in Cleveland heading into neuroscience. Every review is built from public sources: peer-reviewed papers, trial registries and company disclosures.
Reviews are independent analysis, not medical or investment advice.